speb/financial-data huggingface dataset:
ASL.AX balance_sheet (annual, 2022-06-30) — Capital Stock: 4980226.00
ASL.AX balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 3370610.00
ASL.AX balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 3370610.00
ASL.AX balance_sheet (annual, 2022-06-30) — Cash Financial: 3370610.00
ASL.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: 4620181.00
ASL.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Investing Activities: -881458.00
ASL.AX cash_flow (annual, 2022-06-30) — Cash Flowsfromusedin Operating Activities Direct: -622434.00
ASL.AX cash_flow (annual, 2022-06-30) — Changes In Cash: 3116289.00
ASL.AX cash_flow (annual, 2022-06-30) — Classesof Cash Payments: -619973.00
ASL.AX balance_sheet (annual, 2022-06-30) — Common Stock: 4980226.00
ASL.AX balance_sheet (annual, 2022-06-30) — Common Stock Equity: 4235409.00
ASL.AX cash_flow (annual, 2022-06-30) — Common Stock Issuance: 5000000.00
ASL.AX cash_flow (annual, 2022-06-30) — Common Stock Payments: -371844.00
ASL.AX balance_sheet (annual, 2022-06-30) — Current Assets: 3438043.00
ASL.AX balance_sheet (annual, 2022-06-30) — Current Capital Lease Obligation: 9283.00
ASL.AX balance_sheet (annual, 2022-06-30) — Current Debt And Capital Lease Obligation: 9283.00
ASL.AX balance_sheet (annual, 2022-06-30) — Current Liabilities: 83751.00
ASL.AX income_statement (annual, 2022-06-30) — Depreciation Amortization Depletion Income Statement: 17529.00
ASL.AX income_statement (annual, 2022-06-30) — Depreciation And Amortization In Income Statement: 17529.00
ASL.AX income_statement (annual, 2022-06-30) — Depreciation Income Statement: 17529.00
ASL.AX income_statement (annual, 2022-06-30) — Diluted Average Shares: 27967123.00
ASL.AX income_statement (annual, 2022-06-30) — Diluted EPS: -0.02
ASL.AX income_statement (annual, 2022-06-30) — EBIT: -643821.00
ASL.AX income_statement (annual, 2022-06-30) — EBITDA: -626292.00
ASL.AX cash_flow (annual, 2022-06-30) — End Cash Position: 3370610.00
ASL.AX cash_flow (annual, 2022-06-30) — Financing Cash Flow: 4620181.00
ASL.AX cash_flow (annual, 2022-06-30) — Free Cash Flow: -1503892.00
ASL.AX income_statement (annual, 2022-06-30) — General And Administrative Expense: 268681.00
ASL.AX balance_sheet (annual, 2022-06-30) — Gross PPE: 926206.00
ASL.AX income_statement (annual, 2022-06-30) — Interest Expense: 2461.00
ASL.AX income_statement (annual, 2022-06-30) — Interest Expense Non Operating: 2461.00
ASL.AX cash_flow (annual, 2022-06-30) — Interest Paid Direct: -2461.00
ASL.AX cash_flow (annual, 2022-06-30) — Interest Paid Supplemental Data: 2461.00
ASL.AX balance_sheet (annual, 2022-06-30) — Invested Capital: 4235409.00
ASL.AX cash_flow (annual, 2022-06-30) — Investing Cash Flow: -881458.00
ASL.AX cash_flow (annual, 2022-06-30) — Issuance Of Capital Stock: 5000000.00
ASL.AX balance_sheet (annual, 2022-06-30) — Long Term Capital Lease Obligation: 31213.00
ASL.AX balance_sheet (annual, 2022-06-30) — Long Term Debt And Capital Lease Obligation: 31213.00
ASL.AX cash_flow (annual, 2022-06-30) — Long Term Debt Payments: -7975.00
ASL.AX balance_sheet (annual, 2022-06-30) — Machinery Furniture Equipment: 129505.00
ASL.AX cash_flow (annual, 2022-06-30) — Net Common Stock Issuance: 4628156.00
ASL.AX income_statement (annual, 2022-06-30) — Net Income: -646282.00
ASL.AX income_statement (annual, 2022-06-30) — Net Income Common Stockholders: -646282.00
ASL.AX income_statement (annual, 2022-06-30) — Net Income Continuous Operations: -646282.00
ASL.AX income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: -646282.00
ASL.AX income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: -646282.00
ASL.AX income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: -646282.00
ASL.AX income_statement (annual, 2022-06-30) — Net Interest Income: -2461.00
ASL.AX cash_flow (annual, 2022-06-30) — Net Issuance Payments Of Debt: -7975.00
ASL.AX cash_flow (annual, 2022-06-30) — Net Long Term Debt Issuance: -7975.00
ASL.AX income_statement (annual, 2022-06-30) — Net Non Operating Interest Income Expense: -2461.00
ASL.AX balance_sheet (annual, 2022-06-30) — Net PPE: 912330.00
ASL.AX cash_flow (annual, 2022-06-30) — Net PPE Purchase And Sale: -84757.00
ASL.AX balance_sheet (annual, 2022-06-30) — Net Tangible Assets: 4235409.00
ASL.AX income_statement (annual, 2022-06-30) — Normalized EBITDA: -626292.00
ASL.AX income_statement (annual, 2022-06-30) — Normalized Income: -646282.00
ASL.AX income_statement (annual, 2022-06-30) — Operating Income: -643821.00
ASL.AX balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 34200000.00
ASL.AX income_statement (annual, 2022-06-30) — Other Operating Expenses: 271223.00
ASL.AX balance_sheet (annual, 2022-06-30) — Other Payable: 15000.00
ASL.AX balance_sheet (annual, 2022-06-30) — Other Properties: 796701.00
ASL.AX balance_sheet (annual, 2022-06-30) — Other Receivables: 65329.00
ASL.AX balance_sheet (annual, 2022-06-30) — Payables: 64621.00
ASL.AX balance_sheet (annual, 2022-06-30) — Payables And Accrued Expenses: 64621.00
ASL.AX cash_flow (annual, 2022-06-30) — Paymentsto Suppliersfor Goodsand Services: -619973.00
ASL.AX balance_sheet (annual, 2022-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 9847.00
ASL.AX balance_sheet (annual, 2022-06-30) — Prepaid Assets: 2104.00
ASL.AX income_statement (annual, 2022-06-30) — Pretax Income: -646282.00
ASL.AX cash_flow (annual, 2022-06-30) — Purchase Of PPE: -84757.00
ASL.AX balance_sheet (annual, 2022-06-30) — Receivables: 65329.00
ASL.AX income_statement (annual, 2022-06-30) — Reconciled Depreciation: 17529.00
ASL.AX income_statement (annual, 2022-06-30) — Rent And Landing Fees: 3050.00
ASL.AX cash_flow (annual, 2022-06-30) — Repayment Of Debt: -7975.00
ASL.AX cash_flow (annual, 2022-06-30) — Repurchase Of Capital Stock: -371844.00
ASL.AX balance_sheet (annual, 2022-06-30) — Retained Earnings: -744817.00
ASL.AX income_statement (annual, 2022-06-30) — Salaries And Wages: 265631.00
ASL.AX income_statement (annual, 2022-06-30) — Selling And Marketing Expense: 86388.00
ASL.AX income_statement (annual, 2022-06-30) — Selling General And Administration: 355069.00
ASL.AX balance_sheet (annual, 2022-06-30) — Share Issued: 34200000.00
ASL.AX balance_sheet (annual, 2022-06-30) — Stockholders Equity: 4235409.00
ASL.AX balance_sheet (annual, 2022-06-30) — Tangible Book Value: 4235409.00
ASL.AX income_statement (annual, 2022-06-30) — Tax Effect Of Unusual Items: 0.00
ASL.AX income_statement (annual, 2022-06-30) — Tax Provision: 0.00
ASL.AX income_statement (annual, 2022-06-30) — Tax Rate For Calcs: 0.00
ASL.AX balance_sheet (annual, 2022-06-30) — Total Assets: 4350373.00
ASL.AX balance_sheet (annual, 2022-06-30) — Total Capitalization: 4235409.00
ASL.AX balance_sheet (annual, 2022-06-30) — Total Debt: 40496.00
ASL.AX balance_sheet (annual, 2022-06-30) — Total Equity Gross Minority Interest: 4235409.00
ASL.AX balance_sheet (annual, 2022-06-30) — Total Liabilities Net Minority Interest: 114964.00
ASL.AX balance_sheet (annual, 2022-06-30) — Total Non Current Assets: 912330.00
ASL.AX balance_sheet (annual, 2022-06-30) — Total Non Current Liabilities Net Minority Interest: 31213.00
ASL.AX balance_sheet (annual, 2022-06-30) — Working Capital: 3354292.00
ASL.AX income_statement (annual, 2023-06-30) — +Operating Expense: 1672620.00
ASL.AX balance_sheet (annual, 2023-06-30) — Accounts Payable: 89194.00
ASL.AX balance_sheet (annual, 2023-06-30) — Accumulated Depreciation: -33701.00
ASL.AX income_statement (annual, 2023-06-30) — Amortization: 4230.00
ASL.AX income_statement (annual, 2023-06-30) — Amortization Of Intangibles Income Statement: 4230.00
ASL.AX income_statement (annual, 2023-06-30) — Basic Average Shares: 38456538.00
ASL.AX income_statement (annual, 2023-06-30) — Basic EPS: -0.04
ASL.AX cash_flow (annual, 2023-06-30) — Beginning Cash Position: 3370610.00
ASL.AX cash_flow (annual, 2023-06-30) — Capital Expenditure: -669893.00
ASL.AX cash_flow (annual, 2023-06-30) — Capital Expenditure Reported: -589893.00
ASL.AX balance_sheet (annual, 2023-06-30) — Capital Lease Obligations: 31212.00
ASL.AX balance_sheet (annual, 2023-06-30) — Capital Stock: 5871854.00
ASL.AX balance_sheet (annual, 2023-06-30) — Cash And Cash Equivalents: 2678831.00
ASL.AX balance_sheet (annual, 2023-06-30) — Cash Cash Equivalents And Short Term Investments: 2678831.00
ASL.AX balance_sheet (annual, 2023-06-30) — Cash Financial: 2678831.00
ASL.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Financing Activities: 1089299.00
ASL.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Investing Activities: -669893.00
ASL.AX cash_flow (annual, 2023-06-30) — Cash Flowsfromusedin Operating Activities Direct: -1111185.00
ASL.AX cash_flow (annual, 2023-06-30) — Changes In Cash: -691779.00
ASL.AX cash_flow (annual, 2023-06-30) — Classesof Cash Payments: -1081835.00
ASL.AX cash_flow (annual, 2023-06-30) — Classesof Cash Receiptsfrom Operating Activities: -37434.00
ASL.AX balance_sheet (annual, 2023-06-30) — Common Stock: 5871854.00
ASL.AX balance_sheet (annual, 2023-06-30) — Common Stock Equity: 4209007.00
ASL.AX cash_flow (annual, 2023-06-30) — Common Stock Issuance: 1190000.00
ASL.AX cash_flow (annual, 2023-06-30) — Common Stock Payments: -91488.00
ASL.AX balance_sheet (annual, 2023-06-30) — Current Assets: 2708142.00
ASL.AX balance_sheet (annual, 2023-06-30) — Current Capital Lease Obligation: 11384.00
ASL.AX balance_sheet (annual, 2023-06-30) — Current Debt And Capital Lease Obligation: 11384.00
ASL.AX balance_sheet (annual, 2023-06-30) — Current Liabilities: 182732.00
ASL.AX income_statement (annual, 2023-06-30) — Depreciation Amortization Depletion Income Statement: 27779.00
ASL.AX income_statement (annual, 2023-06-30) — Depreciation And Amortization In Income Statement: 27779.00
ASL.AX income_statement (annual, 2023-06-30) — Depreciation Income Statement: 23549.00
ASL.AX income_statement (annual, 2023-06-30) — Diluted Average Shares: 38456538.00
ASL.AX income_statement (annual, 2023-06-30) — Diluted EPS: -0.04
ASL.AX income_statement (annual, 2023-06-30) — EBIT: -1662365.00
ASL.AX income_statement (annual, 2023-06-30) — EBITDA: -1634586.00
ASL.AX cash_flow (annual, 2023-06-30) — End Cash Position: 2678831.00
ASL.AX cash_flow (annual, 2023-06-30) — Financing Cash Flow: 1089299.00
ASL.AX cash_flow (annual, 2023-06-30) — Free Cash Flow: -1781078.00
ASL.AX balance_sheet (annual, 2023-06-30) — Gains Losses Not Affecting Retained Earnings: 746512.00
ASL.AX income_statement (annual, 2023-06-30) — General And Administrative Expense: 1090481.00
ASL.AX balance_sheet (annual, 2023-06-30) — Goodwill And Other Intangible Assets: 95770.00
ASL.AX balance_sheet (annual, 2023-06-30) — Gross PPE: 1581323.00
ASL.AX income_statement (annual, 2023-06-30) — Interest Expense: 2177.00
ASL.AX income_statement (annual, 2023-06-30) — Interest Expense Non Operating: 2177.00
ASL.AX income_statement (annual, 2023-06-30) — Interest Income: 10255.00
ASL.AX income_statement (annual, 2023-06-30) — Interest Income Non Operating: 10255.00
ASL.AX cash_flow (annual, 2023-06-30) — Interest Paid Direct: -2171.00
ASL.AX cash_flow (annual, 2023-06-30) — Interest Paid Supplemental Data: 2171.00
ASL.AX cash_flow (annual, 2023-06-30) — Interest Received Direct: 10255.00
ASL.AX balance_sheet (annual, 2023-06-30) — Invested Capital: 4209007.00
ASL.AX cash_flow (annual, 2023-06-30) — Investing Cash Flow: -669893.00
ASL.AX balance_sheet (annual, 2023-06-30) — Investments And Advances: 60033.00
ASL.AX cash_flow (annual, 2023-06-30) — Issuance Of Capital Stock: 1190000.00
ASL.AX balance_sheet (annual, 2023-06-30) — Long Term Capital Lease Obligation: 19828.00
ASL.AX balance_sheet (annual, 2023-06-30) — Long Term Debt And Capital Lease Obligation: 19828.00
ASL.AX cash_flow (annual, 2023-06-30) — Long Term Debt Payments: -9213.00
ASL.AX balance_sheet (annual, 2023-06-30) — Machinery Furniture Equipment: 129505.00
ASL.AX cash_flow (annual, 2023-06-30) — Net Common Stock Issuance: 1098512.00
ASL.AX income_statement (annual, 2023-06-30) — Net Income: -1664542.00
ASL.AX income_statement (annual, 2023-06-30) — Net Income Common Stockholders: -1664542.00
ASL.AX income_statement (annual, 2023-06-30) — Net Income Continuous Operations: -1664542.00
ASL.AX income_statement (annual, 2023-06-30) — Net Income From Continuing And Discontinued Operation: -1664542.00
ASL.AX income_statement (annual, 2023-06-30) — Net Income From Continuing Operation Net Minority Interest: -1664542.00
ASL.AX income_statement (annual, 2023-06-30) — Net Income Including Noncontrolling Interests: -1664542.00
ASL.AX income_statement (annual, 2023-06-30) — Net Interest Income: 8078.00
ASL.AX cash_flow (annual, 2023-06-30) — Net Issuance Payments Of Debt: -9213.00
ASL.AX cash_flow (annual, 2023-06-30) — Net Long Term Debt Issuance: -9213.00
ASL.AX income_statement (annual, 2023-06-30) — Net Non Operating Interest Income Expense: 8078.00
ASL.AX balance_sheet (annual, 2023-06-30) — Net PPE: 1547622.00
ASL.AX cash_flow (annual, 2023-06-30) — Net PPE Purchase And Sale: -80000.00
ASL.AX balance_sheet (annual, 2023-06-30) — Net Tangible Assets: 4113237.00
ASL.AX income_statement (annual, 2023-06-30) — Normalized EBITDA: -1634586.00
ASL.AX income_statement (annual, 2023-06-30) — Normalized Income: -1664542.00
ASL.AX income_statement (annual, 2023-06-30) — Operating Income: -1672620.00
ASL.AX balance_sheet (annual, 2023-06-30) — Ordinary Shares Number: 45350100.00
ASL.AX cash_flow (annual, 2023-06-30) — Other Cash Receiptsfrom Operating Activities: -37434.00
ASL.AX balance_sheet (annual, 2023-06-30) — Other Equity Adjustments: 746512.00
ASL.AX income_statement (annual, 2023-06-30) — Other Gand A: 385901.00
ASL.AX balance_sheet (annual, 2023-06-30) — Other Intangible Assets: 95770.00
ASL.AX balance_sheet (annual, 2023-06-30) — Other Investments: 60033.00
ASL.AX income_statement (annual, 2023-06-30) — Other Operating Expenses: 554360.00
ASL.AX balance_sheet (annual, 2023-06-30) — Other Payable: 64317.00
ASL.AX balance_sheet (annual, 2023-06-30) — Other Properties: 1451818.00
ASL.AX balance_sheet (annual, 2023-06-30) — Other Receivables: 11832.00
ASL.AX balance_sheet (annual, 2023-06-30) — Payables: 153511.00
ASL.AX balance_sheet (annual, 2023-06-30) — Payables And Accrued Expenses: 153511.00
ASL.AX cash_flow (annual, 2023-06-30) — Paymentsto Suppliersfor Goodsand Services: -1081835.00
ASL.AX balance_sheet (annual, 2023-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 17837.00
ASL.AX balance_sheet (annual, 2023-06-30) — Prepaid Assets: 17479.00
ASL.AX income_statement (annual, 2023-06-30) — Pretax Income: -1664542.00
ASL.AX cash_flow (annual, 2023-06-30) — Purchase Of PPE: -80000.00
ASL.AX balance_sheet (annual, 2023-06-30) — Receivables: 11832.00
ASL.AX income_statement (annual, 2023-06-30) — Reconciled Depreciation: 27779.00
ASL.AX income_statement (annual, 2023-06-30) — Rent And Landing Fees: 17257.00
ASL.AX cash_flow (annual, 2023-06-30) — Repayment Of Debt: -9213.00
ASL.AX cash_flow (annual, 2023-06-30) — Repurchase Of Capital Stock: -91488.00
ASL.AX balance_sheet (annual, 2023-06-30) — Retained Earnings: -2409359.00
ASL.AX income_statement (annual, 2023-06-30) — Salaries And Wages: 687323.00
ASL.AX income_statement (annual, 2023-06-30) — Selling General And Administration: 1090481.00
ASL.AX balance_sheet (annual, 2023-06-30) — Share Issued: 45350100.00
ASL.AX balance_sheet (annual, 2023-06-30) — Stockholders Equity: 4209007.00
ASL.AX balance_sheet (annual, 2023-06-30) — Tangible Book Value: 4113237.00
ASL.AX income_statement (annual, 2023-06-30) — Tax Effect Of Unusual Items: 0.00
ASL.AX income_statement (annual, 2023-06-30) — Tax Provision: 0.00
ASL.AX income_statement (annual, 2023-06-30) — Tax Rate For Calcs: 0.00
ASL.AX balance_sheet (annual, 2023-06-30) — Total Assets: 4411567.00
ASL.AX balance_sheet (annual, 2023-06-30) — Total Capitalization: 4209007.00
ASL.AX balance_sheet (annual, 2023-06-30) — Total Debt: 31212.00
ASL.AX balance_sheet (annual, 2023-06-30) — Total Equity Gross Minority Interest: 4209007.00
ASL.AX balance_sheet (annual, 2023-06-30) — Total Liabilities Net Minority Interest: 202560.00
ASL.AX balance_sheet (annual, 2023-06-30) — Total Non Current Assets: 1703425.00
ASL.AX balance_sheet (annual, 2023-06-30) — Total Non Current Liabilities Net Minority Interest: 19828.00
ASL.AX balance_sheet (annual, 2023-06-30) — Working Capital: 2525410.00
ASL.AX income_statement (annual, 2024-06-30) — +Operating Expense: 10010170.00
ASL.AX balance_sheet (annual, 2024-06-30) — Accounts Payable: 987145.00
ASL.AX balance_sheet (annual, 2024-06-30) — Accumulated Depreciation: -168600.00
ASL.AX income_statement (annual, 2024-06-30) — Amortization: 20000.00
ASL.AX income_statement (annual, 2024-06-30) — Amortization Of Intangibles Income Statement: 20000.00
ASL.AX income_statement (annual, 2024-06-30) — Basic Average Shares: 67604997.00
ASL.AX income_statement (annual, 2024-06-30) — Basic EPS: -0.15
ASL.AX cash_flow (annual, 2024-06-30) — Beginning Cash Position: 2678831.00
ASL.AX cash_flow (annual, 2024-06-30) — Capital Expenditure: -6346041.00
ASL.AX cash_flow (annual, 2024-06-30) — Capital Expenditure Reported: -2043487.00
ASL.AX balance_sheet (annual, 2024-06-30) — Capital Lease Obligations: 112628.00
ASL.AX balance_sheet (annual, 2024-06-30) — Capital Stock: 23820194.00
ASL.AX balance_sheet (annual, 2024-06-30) — Cash And Cash Equivalents: 9924422.00
ASL.AX balance_sheet (annual, 2024-06-30) — Cash Cash Equivalents And Short Term Investments: 9924422.00
ASL.AX balance_sheet (annual, 2024-06-30) — Cash Financial: 9924422.00
ASL.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Financing Activities: 17491138.00
ASL.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Investing Activities: -6346041.00
ASL.AX cash_flow (annual, 2024-06-30) — Cash Flowsfromusedin Operating Activities Direct: -3899506.00
ASL.AX cash_flow (annual, 2024-06-30) — Changes In Cash: 7245591.00
ASL.AX cash_flow (annual, 2024-06-30) — Classesof Cash Payments: -4026932.00
ASL.AX cash_flow (annual, 2024-06-30) — Classesof Cash Receiptsfrom Operating Activities: 93639.00
ASL.AX balance_sheet (annual, 2024-06-30) — Common Stock: 23820194.00
ASL.AX balance_sheet (annual, 2024-06-30) — Common Stock Equity: 16663253.00
ASL.AX cash_flow (annual, 2024-06-30) — Common Stock Issuance: 18571000.00
ASL.AX cash_flow (annual, 2024-06-30) — Common Stock Payments: -1011521.00
ASL.AX balance_sheet (annual, 2024-06-30) — Current Assets: 10076594.00
ASL.AX balance_sheet (annual, 2024-06-30) — Current Capital Lease Obligation: 102566.00
ASL.AX balance_sheet (annual, 2024-06-30) — Current Debt And Capital Lease Obligation: 102566.00
ASL.AX balance_sheet (annual, 2024-06-30) — Current Deferred Liabilities: 1000000.00
ASL.AX balance_sheet (annual, 2024-06-30) — Current Deferred Revenue: 1000000.00
ASL.AX balance_sheet (annual, 2024-06-30) — Current Liabilities: 3303878.00
ASL.AX income_statement (annual, 2024-06-30) — Depreciation Amortization Depletion Income Statement: 145207.00
ASL.AX income_statement (annual, 2024-06-30) — Depreciation And Amortization In Income Statement: 145207.00
ASL.AX income_statement (annual, 2024-06-30) — Depreciation Income Statement: 125207.00
ASL.AX income_statement (annual, 2024-06-30) — Diluted Average Shares: 67604997.00
ASL.AX income_statement (annual, 2024-06-30) — Diluted EPS: -0.15
ASL.AX income_statement (annual, 2024-06-30) — EBIT: -9733355.00
ASL.AX income_statement (annual, 2024-06-30) — EBITDA: -9588148.00
ASL.AX cash_flow (annual, 2024-06-30) — End Cash Position: 9924422.00
ASL.AX cash_flow (annual, 2024-06-30) — Financing Cash Flow: 17491138.00
ASL.AX balance_sheet (annual, 2024-06-30) — Foreign Currency Translation Adjustments: 210628.00
ASL.AX cash_flow (annual, 2024-06-30) — Free Cash Flow: -10245547.00
ASL.AX balance_sheet (annual, 2024-06-30) — Gains Losses Not Affecting Retained Earnings: 5377852.00
ASL.AX income_statement (annual, 2024-06-30) — General And Administrative Expense: 6124335.00
ASL.AX balance_sheet (annual, 2024-06-30) — Goodwill And Other Intangible Assets: 75770.00
ASL.AX balance_sheet (annual, 2024-06-30) — Gross PPE: 21484125.00
ASL.AX income_statement (annual, 2024-06-30) — Interest Expense: 392079.00
ASL.AX income_statement (annual, 2024-06-30) — Interest Expense Non Operating: 392079.00
ASL.AX income_statement (annual, 2024-06-30) — Interest Income: 225703.00
ASL.AX income_statement (annual, 2024-06-30) — Interest Income Non Operating: 225703.00
ASL.AX cash_flow (annual, 2024-06-30) — Interest Paid Direct: -1602.00
ASL.AX cash_flow (annual, 2024-06-30) — Interest Paid Supplemental Data: 1602.00
ASL.AX cash_flow (annual, 2024-06-30) — Interest Received Direct: 35389.00
ASL.AX balance_sheet (annual, 2024-06-30) — Invested Capital: 16663253.00
ASL.AX cash_flow (annual, 2024-06-30) — Investing Cash Flow: -6346041.00
ASL.AX balance_sheet (annual, 2024-06-30) — Investments And Advances: 85034.00
ASL.AX cash_flow (annual, 2024-06-30) — Issuance Of Capital Stock: 18571000.00
ASL.AX balance_sheet (annual, 2024-06-30) — Long Term Capital Lease Obligation: 10062.00
ASL.AX balance_sheet (annual, 2024-06-30) — Long Term Debt And Capital Lease Obligation: 10062.00
ASL.AX cash_flow (annual, 2024-06-30) — Long Term Debt Payments: -68341.00
ASL.AX balance_sheet (annual, 2024-06-30) — Long Term Provisions: 18463960.00
ASL.AX balance_sheet (annual, 2024-06-30) — Machinery Furniture Equipment: 428632.00
ASL.AX cash_flow (annual, 2024-06-30) — Net Common Stock Issuance: 17559479.00
ASL.AX income_statement (annual, 2024-06-30) — Net Income: -10125434.00
ASL.AX income_statement (annual, 2024-06-30) — Net Income Common Stockholders: -10125434.00
ASL.AX income_statement (annual, 2024-06-30) — Net Income Continuous Operations: -10125434.00
ASL.AX income_statement (annual, 2024-06-30) — Net Income From Continuing And Discontinued Operation: -10125434.00
ASL.AX income_statement (annual, 2024-06-30) — Net Income From Continuing Operation Net Minority Interest: -10125434.00
ASL.AX income_statement (annual, 2024-06-30) — Net Income Including Noncontrolling Interests: -10125434.00
ASL.AX income_statement (annual, 2024-06-30) — Net Interest Income: -166376.00
ASL.AX cash_flow (annual, 2024-06-30) — Net Issuance Payments Of Debt: -68341.00
ASL.AX cash_flow (annual, 2024-06-30) — Net Long Term Debt Issuance: -68341.00
ASL.AX income_statement (annual, 2024-06-30) — Net Non Operating Interest Income Expense: -166376.00
ASL.AX balance_sheet (annual, 2024-06-30) — Net PPE: 21315525.00
ASL.AX cash_flow (annual, 2024-06-30) — Net PPE Purchase And Sale: -4302554.00
ASL.AX balance_sheet (annual, 2024-06-30) — Net Tangible Assets: 16587483.00
ASL.AX balance_sheet (annual, 2024-06-30) — Non Current Accounts Receivable: 5888230.00
ASL.AX income_statement (annual, 2024-06-30) — Normalized EBITDA: -9588148.00
ASL.AX income_statement (annual, 2024-06-30) — Normalized Income: -10125434.00
ASL.AX income_statement (annual, 2024-06-30) — Operating Income: -10010170.00
ASL.AX balance_sheet (annual, 2024-06-30) — Ordinary Shares Number: 111987136.00
ASL.AX cash_flow (annual, 2024-06-30) — Other Cash Receiptsfrom Operating Activities: 93639.00
ASL.AX balance_sheet (annual, 2024-06-30) — Other Current Liabilities: 1000000.00
ASL.AX balance_sheet (annual, 2024-06-30) — Other Equity Adjustments: 5167224.00
ASL.AX income_statement (annual, 2024-06-30) — Other Gand A: 994483.00
ASL.AX income_statement (annual, 2024-06-30) — Other Income Expense: 51112.00
ASL.AX balance_sheet (annual, 2024-06-30) — Other Intangible Assets: 75770.00
ASL.AX balance_sheet (annual, 2024-06-30) — Other Investments: 85034.00
ASL.AX income_statement (annual, 2024-06-30) — Other Non Operating Income Expenses: 51112.00
ASL.AX income_statement (annual, 2024-06-30) — Other Operating Expenses: 3563280.00
ASL.AX balance_sheet (annual, 2024-06-30) — Other Payable: 73786.00
ASL.AX balance_sheet (annual, 2024-06-30) — Other Properties: 21055493.00
ASL.AX balance_sheet (annual, 2024-06-30) — Other Receivables: 76332.00
ASL.AX balance_sheet (annual, 2024-06-30) — Payables: 1060931.00
ASL.AX balance_sheet (annual, 2024-06-30) — Payables And Accrued Expenses: 1060931.00
ASL.AX cash_flow (annual, 2024-06-30) — Paymentsto Suppliersfor Goodsand Services: -4026932.00
ASL.AX balance_sheet (annual, 2024-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 140381.00
ASL.AX balance_sheet (annual, 2024-06-30) — Prepaid Assets: 75840.00
ASL.AX income_statement (annual, 2024-06-30) — Pretax Income: -10125434.00
ASL.AX income_statement (annual, 2024-06-30) — Provision For Doubtful Accounts: 177348.00
ASL.AX cash_flow (annual, 2024-06-30) — Purchase Of PPE: -4302554.00
ASL.AX balance_sheet (annual, 2024-06-30) — Receivables: 76332.00
ASL.AX income_statement (annual, 2024-06-30) — Reconciled Depreciation: 145207.00
ASL.AX income_statement (annual, 2024-06-30) — Rent And Landing Fees: 130465.00
ASL.AX cash_flow (annual, 2024-06-30) — Repayment Of Debt: -68341.00
ASL.AX cash_flow (annual, 2024-06-30) — Repurchase Of Capital Stock: -1011521.00
ASL.AX balance_sheet (annual, 2024-06-30) — Retained Earnings: -12534793.00
ASL.AX income_statement (annual, 2024-06-30) — Salaries And Wages: 4999387.00
ASL.AX income_statement (annual, 2024-06-30) — Selling General And Administration: 6124335.00
ASL.AX balance_sheet (annual, 2024-06-30) — Share Issued: 111987136.00
ASL.AX balance_sheet (annual, 2024-06-30) — Stockholders Equity: 16663253.00
ASL.AX balance_sheet (annual, 2024-06-30) — Tangible Book Value: 16587483.00
ASL.AX income_statement (annual, 2024-06-30) — Tax Effect Of Unusual Items: 0.00
ASL.AX income_statement (annual, 2024-06-30) — Tax Provision: 0.00
ASL.AX income_statement (annual, 2024-06-30) — Tax Rate For Calcs: 0.00
ASL.AX balance_sheet (annual, 2024-06-30) — Total Assets: 37441153.00
ASL.AX balance_sheet (annual, 2024-06-30) — Total Capitalization: 16663253.00
ASL.AX balance_sheet (annual, 2024-06-30) — Total Debt: 112628.00
ASL.AX balance_sheet (annual, 2024-06-30) — Total Equity Gross Minority Interest: 16663253.00
ASL.AX balance_sheet (annual, 2024-06-30) — Total Liabilities Net Minority Interest: 21777900.00
ASL.AX balance_sheet (annual, 2024-06-30) — Total Non Current Assets: 27364559.00
ASL.AX balance_sheet (annual, 2024-06-30) — Total Non Current Liabilities Net Minority Interest: 18474022.00
ASL.AX balance_sheet (annual, 2024-06-30) — Working Capital: 6772716.00
ASL.L cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: 0.00
ASL.L balance_sheet (annual, 2021-12-31) — Treasury Shares Number: 0.00
ASL.L income_statement (annual, 2022-12-31) — +Operating Expense: 2951000.00
ASL.L income_statement (annual, 2022-12-31) — +Total Revenue: -153741000.00
ASL.L balance_sheet (annual, 2022-12-31) — Accounts Payable: 133000.00
ASL.L balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 135000.00
ASL.L income_statement (annual, 2022-12-31) — Basic Average Shares: 86570115.00
ASL.L income_statement (annual, 2022-12-31) — Basic EPS: -1.81
ASL.L cash_flow (annual, 2022-12-31) — Beginning Cash Position: 3418000.00
ASL.L balance_sheet (annual, 2022-12-31) — Capital Stock: 853000.00
ASL.L balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 1668000.00
ASL.L balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 1668000.00
ASL.L cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -31707000.00
ASL.L balance_sheet (annual, 2022-12-31) — Cash Financial: 1668000.00
ASL.L cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 0.00
ASL.L cash_flow (annual, 2022-12-31) — Change In Payable: -24000.00
ASL.L cash_flow (annual, 2022-12-31) — Change In Receivables: -365000.00
ASL.L cash_flow (annual, 2022-12-31) — Change In Working Capital: -389000.00
ASL.L cash_flow (annual, 2022-12-31) — Changes In Cash: -1750000.00
ASL.L balance_sheet (annual, 2022-12-31) — Common Stock: 853000.00
ASL.L cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -31707000.00
ASL.L balance_sheet (annual, 2022-12-31) — Common Stock Equity: 1250870000.00
ASL.L cash_flow (annual, 2022-12-31) — Common Stock Payments: -34026000.00
ASL.L income_statement (annual, 2022-12-31) — Diluted Average Shares: 86570115.00
ASL.L income_statement (annual, 2022-12-31) — Diluted EPS: -1.81
ASL.L income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -156692000.00
ASL.L cash_flow (annual, 2022-12-31) — End Cash Position: 1668000.00
ASL.L balance_sheet (annual, 2022-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1322261000.00
ASL.L cash_flow (annual, 2022-12-31) — Financing Cash Flow: -78965000.00
ASL.L cash_flow (annual, 2022-12-31) — Free Cash Flow: 42630000.00
ASL.L income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 56896000.00
ASL.L income_statement (annual, 2022-12-31) — General And Administrative Expense: 2886000.00
ASL.L income_statement (annual, 2022-12-31) — Interest Expense: 1812000.00
ASL.L income_statement (annual, 2022-12-31) — Interest Income: 7000.00
ASL.L cash_flow (annual, 2022-12-31) — Interest Paid Cff: -1732000.00
ASL.L balance_sheet (annual, 2022-12-31) — Invested Capital: 1325843000.00
ASL.L cash_flow (annual, 2022-12-31) — Investing Cash Flow: 34585000.00
ASL.L balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 1322261000.00
ASL.L balance_sheet (annual, 2022-12-31) — Investments And Advances: 1322261000.00
ASL.L cash_flow (annual, 2022-12-31) — Issuance Of Debt: 126000000.00
ASL.L balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 74973000.00
ASL.L cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 126000000.00
ASL.L cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -137500000.00
ASL.L cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -34026000.00
ASL.L balance_sheet (annual, 2022-12-31) — Net Debt: 73305000.00
ASL.L income_statement (annual, 2022-12-31) — Net Income: -156692000.00
ASL.L income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -156692000.00
ASL.L income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -156692000.00
ASL.L income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -156692000.00
ASL.L income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -156692000.00
ASL.L cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 48874000.00
ASL.L income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -156692000.00
ASL.L income_statement (annual, 2022-12-31) — Net Interest Income: -1805000.00
ASL.L cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 34585000.00
ASL.L cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -11500000.00
ASL.L cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -11500000.00
ASL.L cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 0.00
ASL.L balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 1250870000.00
ASL.L income_statement (annual, 2022-12-31) — Normalized Income: -156692000.00
ASL.L cash_flow (annual, 2022-12-31) — Operating Cash Flow: 42630000.00
ASL.L income_statement (annual, 2022-12-31) — Operating Revenue: -153741000.00
ASL.L balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 85344605.00
ASL.L income_statement (annual, 2022-12-31) — Other Operating Expenses: 65000.00
ASL.L balance_sheet (annual, 2022-12-31) — Other Payable: 98000.00
ASL.L balance_sheet (annual, 2022-12-31) — Payables: 231000.00
ASL.L income_statement (annual, 2022-12-31) — Pretax Income: -156692000.00
ASL.L cash_flow (annual, 2022-12-31) — Purchase Of Investment: -250161000.00
ASL.L balance_sheet (annual, 2022-12-31) — Receivables: 2145000.00
ASL.L cash_flow (annual, 2022-12-31) — Repayment Of Debt: -137500000.00
ASL.L cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -34026000.00
ASL.L cash_flow (annual, 2022-12-31) — Sale Of Investment: 284746000.00
ASL.L income_statement (annual, 2022-12-31) — Selling General And Administration: 2886000.00
ASL.L balance_sheet (annual, 2022-12-31) — Share Issued: 85344605.00
ASL.L balance_sheet (annual, 2022-12-31) — Stockholders Equity: 1250870000.00
ASL.L balance_sheet (annual, 2022-12-31) — Tangible Book Value: 1250870000.00
ASL.L income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
ASL.L income_statement (annual, 2022-12-31) — Tax Provision: 0.00
ASL.L income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
ASL.L balance_sheet (annual, 2022-12-31) — Taxes Receivable: 0.00
ASL.L cash_flow (annual, 2022-12-31) — Taxes Refund Paid: 0.00
ASL.L balance_sheet (annual, 2022-12-31) — Total Assets: 1326074000.00
ASL.L balance_sheet (annual, 2022-12-31) — Total Capitalization: 1325843000.00
ASL.L balance_sheet (annual, 2022-12-31) — Total Debt: 74973000.00
ASL.L balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 1250870000.00
ASL.L balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 75204000.00
ASL.L balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 0.00
ASL.L income_statement (annual, 2023-12-31) — +Operating Expense: 2743000.00
ASL.L income_statement (annual, 2023-12-31) — +Total Revenue: 101869000.00
ASL.L balance_sheet (annual, 2023-12-31) — Accounts Payable: 207000.00
ASL.L balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 144000.00
ASL.L income_statement (annual, 2023-12-31) — Basic Average Shares: 84766084.00
ASL.L income_statement (annual, 2023-12-31) — Basic EPS: 1.17
ASL.L cash_flow (annual, 2023-12-31) — Beginning Cash Position: 1668000.00
ASL.L balance_sheet (annual, 2023-12-31) — Capital Stock: 844000.00
ASL.L balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 2734000.00
ASL.L balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 2734000.00
ASL.L cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -41046000.00
ASL.L balance_sheet (annual, 2023-12-31) — Cash Financial: 2734000.00
ASL.L cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 0.00
ASL.L cash_flow (annual, 2023-12-31) — Change In Payable: 0.00
ASL.L cash_flow (annual, 2023-12-31) — Change In Receivables: -516000.00
ASL.L cash_flow (annual, 2023-12-31) — Change In Working Capital: -516000.00
ASL.L cash_flow (annual, 2023-12-31) — Changes In Cash: 1066000.00
ASL.L balance_sheet (annual, 2023-12-31) — Common Stock: 844000.00
ASL.L cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -41046000.00
ASL.L balance_sheet (annual, 2023-12-31) — Common Stock Equity: 1297227000.00
ASL.L cash_flow (annual, 2023-12-31) — Common Stock Payments: -11641000.00
ASL.L income_statement (annual, 2023-12-31) — Diluted Average Shares: 84766084.00
ASL.L income_statement (annual, 2023-12-31) — Diluted EPS: 1.17
ASL.L income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 99044000.00
ASL.L cash_flow (annual, 2023-12-31) — End Cash Position: 2734000.00
ASL.L balance_sheet (annual, 2023-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1363980000.00
ASL.L cash_flow (annual, 2023-12-31) — Financing Cash Flow: -59952000.00
ASL.L cash_flow (annual, 2023-12-31) — Free Cash Flow: 46160000.00
ASL.L income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 59725000.00
ASL.L income_statement (annual, 2023-12-31) — General And Administrative Expense: 2678000.00
ASL.L income_statement (annual, 2023-12-31) — Interest Expense: 4144000.00
ASL.L income_statement (annual, 2023-12-31) — Interest Income: 91000.00
ASL.L cash_flow (annual, 2023-12-31) — Interest Paid Cff: -4265000.00
ASL.L balance_sheet (annual, 2023-12-31) — Invested Capital: 1369070000.00
ASL.L cash_flow (annual, 2023-12-31) — Investing Cash Flow: 14858000.00
ASL.L balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 1363980000.00
ASL.L balance_sheet (annual, 2023-12-31) — Investments And Advances: 1363980000.00
ASL.L cash_flow (annual, 2023-12-31) — Issuance Of Debt: 52000000.00
ASL.L balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 71843000.00
ASL.L cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 52000000.00
ASL.L cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -55000000.00
ASL.L cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -11641000.00
ASL.L balance_sheet (annual, 2023-12-31) — Net Debt: 69109000.00
ASL.L income_statement (annual, 2023-12-31) — Net Income: 99044000.00
ASL.L income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 99044000.00
ASL.L income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 99044000.00
ASL.L income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 99044000.00
ASL.L income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 99044000.00
ASL.L cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 52341000.00
ASL.L income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 99044000.00
ASL.L income_statement (annual, 2023-12-31) — Net Interest Income: -4053000.00
ASL.L cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 14858000.00
ASL.L cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -3000000.00
ASL.L cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -3000000.00
ASL.L cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 0.00
ASL.L balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 1297227000.00
ASL.L income_statement (annual, 2023-12-31) — Normalized Income: 99044000.00
ASL.L cash_flow (annual, 2023-12-31) — Operating Cash Flow: 46160000.00
ASL.L income_statement (annual, 2023-12-31) — Operating Revenue: 101869000.00
ASL.L balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 84414605.00
ASL.L income_statement (annual, 2023-12-31) — Other Operating Expenses: 65000.00
ASL.L balance_sheet (annual, 2023-12-31) — Other Payable: 98000.00
ASL.L balance_sheet (annual, 2023-12-31) — Payables: 305000.00
ASL.L income_statement (annual, 2023-12-31) — Pretax Income: 99126000.00
ASL.L cash_flow (annual, 2023-12-31) — Purchase Of Investment: -255193000.00
ASL.L balance_sheet (annual, 2023-12-31) — Receivables: 2621000.00
ASL.L cash_flow (annual, 2023-12-31) — Repayment Of Debt: -55000000.00
ASL.L cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -11641000.00
ASL.L cash_flow (annual, 2023-12-31) — Sale Of Investment: 270051000.00
ASL.L income_statement (annual, 2023-12-31) — Selling General And Administration: 2678000.00
ASL.L balance_sheet (annual, 2023-12-31) — Share Issued: 84414605.00
ASL.L balance_sheet (annual, 2023-12-31) — Stockholders Equity: 1297227000.00
ASL.L balance_sheet (annual, 2023-12-31) — Tangible Book Value: 1297227000.00
ASL.L income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
ASL.L income_statement (annual, 2023-12-31) — Tax Provision: 82000.00
ASL.L income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
ASL.L balance_sheet (annual, 2023-12-31) — Taxes Receivable: 40000.00
ASL.L cash_flow (annual, 2023-12-31) — Taxes Refund Paid: -82000.00
ASL.L balance_sheet (annual, 2023-12-31) — Total Assets: 1369375000.00
ASL.L balance_sheet (annual, 2023-12-31) — Total Capitalization: 1369070000.00
ASL.L balance_sheet (annual, 2023-12-31) — Total Debt: 71843000.00
ASL.L balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 1297227000.00
ASL.L balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 72148000.00
ASL.L balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
ASL.L income_statement (annual, 2024-12-31) — +Operating Expense: 3102000.00
ASL.L income_statement (annual, 2024-12-31) — +Total Revenue: 154693000.00
ASL.L balance_sheet (annual, 2024-12-31) — Accounts Payable: 162000.00
ASL.L balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 162000.00
ASL.L balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 150000.00
ASL.L balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 150000.00
ASL.L income_statement (annual, 2024-12-31) — Basic Average Shares: 84175009.00
ASL.L income_statement (annual, 2024-12-31) — Basic EPS: 1.80
ASL.L cash_flow (annual, 2024-12-31) — Beginning Cash Position: 2734000.00
ASL.L balance_sheet (annual, 2024-12-31) — Capital Stock: 838000.00
ASL.L balance_sheet (quarterly, 2024-12-31) — Capital Stock: 838000.00
ASL.L balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 1349000.00
ASL.L balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 1349000.00
ASL.L balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 1349000.00
ASL.L balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 1349000.00
ASL.L cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -43130000.00
ASL.L balance_sheet (annual, 2024-12-31) — Cash Financial: 1349000.00
ASL.L balance_sheet (quarterly, 2024-12-31) — Cash Financial: 1349000.00
ASL.L cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 0.00
ASL.L cash_flow (annual, 2024-12-31) — Change In Payable: 8000.00
ASL.L cash_flow (annual, 2024-12-31) — Change In Receivables: -213000.00
ASL.L cash_flow (annual, 2024-12-31) — Change In Working Capital: -205000.00
ASL.L cash_flow (annual, 2024-12-31) — Changes In Cash: -1385000.00
ASL.L balance_sheet (annual, 2024-12-31) — Common Stock: 838000.00
ASL.L balance_sheet (quarterly, 2024-12-31) — Common Stock: 838000.00
ASL.L cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -43130000.00
ASL.L balance_sheet (annual, 2024-12-31) — Common Stock Equity: 1397317000.00
ASL.L balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 1397317000.00
ASL.L cash_flow (annual, 2024-12-31) — Common Stock Payments: -8371000.00
ASL.L income_statement (annual, 2024-12-31) — Diluted Average Shares: 84175009.00
ASL.L income_statement (annual, 2024-12-31) — Diluted EPS: 1.80
ASL.L income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 151591000.00
ASL.L cash_flow (annual, 2024-12-31) — Dividend Received Cfo: 0.00
ASL.L cash_flow (annual, 2024-12-31) — End Cash Position: 1349000.00
ASL.L balance_sheet (annual, 2024-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1497304000.00
ASL.L balance_sheet (quarterly, 2024-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1497304000.00
ASL.L cash_flow (annual, 2024-12-31) — Financing Cash Flow: -25953000.00
ASL.L cash_flow (annual, 2024-12-31) — Free Cash Flow: 43673000.00
ASL.L income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 114531000.00
ASL.L income_statement (annual, 2024-12-31) — General And Administrative Expense: 3037000.00
ASL.L income_statement (annual, 2024-12-31) — Interest Expense: 6407000.00
ASL.L income_statement (annual, 2024-12-31) — Interest Income: 118000.00
ASL.L cash_flow (annual, 2024-12-31) — Interest Paid Cff: -6452000.00
ASL.L balance_sheet (annual, 2024-12-31) — Invested Capital: 1501225000.00
ASL.L balance_sheet (quarterly, 2024-12-31) — Invested Capital: 1501225000.00
ASL.L cash_flow (annual, 2024-12-31) — Investing Cash Flow: -19105000.00
ASL.L balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 1497304000.00
ASL.L balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 1497304000.00
ASL.L balance_sheet (annual, 2024-12-31) — Investments And Advances: 1497304000.00
ASL.L balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 1497304000.00
ASL.L cash_flow (annual, 2024-12-31) — Issuance Of Debt: 79000000.00
ASL.L balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 103908000.00
ASL.L balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 103908000.00
ASL.L cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 79000000.00
ASL.L cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -47000000.00
ASL.L cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -8371000.00
ASL.L balance_sheet (annual, 2024-12-31) — Net Debt: 102559000.00
ASL.L balance_sheet (quarterly, 2024-12-31) — Net Debt: 102559000.00
ASL.L income_statement (annual, 2024-12-31) — Net Income: 151591000.00
ASL.L income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 151591000.00
ASL.L income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 151591000.00
ASL.L income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 151591000.00
ASL.L income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 151591000.00
ASL.L cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 50058000.00
ASL.L income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 151591000.00
ASL.L income_statement (annual, 2024-12-31) — Net Interest Income: -6289000.00
ASL.L cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -19105000.00
ASL.L cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 32000000.00
ASL.L cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 32000000.00
ASL.L cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 0.00
ASL.L balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 1397317000.00
ASL.L balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 1397317000.00
ASL.L income_statement (annual, 2024-12-31) — Normalized Income: 151591000.00
ASL.L cash_flow (annual, 2024-12-31) — Operating Cash Flow: 43673000.00
ASL.L income_statement (annual, 2024-12-31) — Operating Revenue: 154693000.00
ASL.L balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 83824605.00
ASL.L balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 83824605.00
ASL.L income_statement (annual, 2024-12-31) — Other Operating Expenses: 65000.00
ASL.L balance_sheet (annual, 2024-12-31) — Other Payable: 140000.00
ASL.L balance_sheet (quarterly, 2024-12-31) — Other Payable: 140000.00
ASL.L balance_sheet (annual, 2024-12-31) — Payables: 302000.00
ASL.L balance_sheet (quarterly, 2024-12-31) — Payables: 302000.00
ASL.L income_statement (annual, 2024-12-31) — Pretax Income: 151591000.00
ASL.L cash_flow (annual, 2024-12-31) — Purchase Of Investment: -307701000.00
ASL.L balance_sheet (annual, 2024-12-31) — Receivables: 2827000.00
ASL.L balance_sheet (quarterly, 2024-12-31) — Receivables: 2827000.00
ASL.L cash_flow (annual, 2024-12-31) — Repayment Of Debt: -47000000.00
ASL.L cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -8371000.00
ASL.L cash_flow (annual, 2024-12-31) — Sale Of Investment: 288596000.00
ASL.L income_statement (annual, 2024-12-31) — Selling General And Administration: 3037000.00
ASL.L balance_sheet (annual, 2024-12-31) — Share Issued: 83824605.00
ASL.L balance_sheet (quarterly, 2024-12-31) — Share Issued: 83824605.00
ASL.L balance_sheet (annual, 2024-12-31) — Stockholders Equity: 1397317000.00
ASL.L balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 1397317000.00
ASL.L balance_sheet (annual, 2024-12-31) — Tangible Book Value: 1397317000.00
ASL.L balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 1397317000.00
ASL.L income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
ASL.L income_statement (annual, 2024-12-31) — Tax Provision: 0.00
ASL.L income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
ASL.L balance_sheet (annual, 2024-12-31) — Taxes Receivable: 47000.00
ASL.L balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 47000.00
ASL.L cash_flow (annual, 2024-12-31) — Taxes Refund Paid: 0.00
ASL.L balance_sheet (annual, 2024-12-31) — Total Assets: 1501527000.00
ASL.L balance_sheet (quarterly, 2024-12-31) — Total Assets: 1501527000.00
ASL.L balance_sheet (annual, 2024-12-31) — Total Capitalization: 1501225000.00
ASL.L balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 1501225000.00
ASL.L balance_sheet (annual, 2024-12-31) — Total Debt: 103908000.00
ASL.L balance_sheet (quarterly, 2024-12-31) — Total Debt: 103908000.00
ASL.L balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 1397317000.00
ASL.L balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 1397317000.00
ASL.L balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 104210000.00
ASL.L balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 104210000.00
ASL.L balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 172000.00